If you didn’t get the chance to join our expert panel in discussing the highlights from ESMO 2020 GI clinical tracks and what they mean for clinical practice in Australia, you can now watch the webcast on demand.
Hosted by:
Doctor David Pook. Medical Oncologist, Monash Health and Cabrini Health; Research Fellow, Prostate Cancer Research Group, Monash University; Deputy Chair, Renal Cell Cancer Subcommittee, Australia and New Zealand Urogenital and Prostate Cancer Trials Group.
Associate Professor Andrew Weickhardt. Translational Scientist and Medical Oncologist, Olivia Newton-John Cancer Research Institute; Associate Professor, School of Cancer Medicine, La Trobe University.
Doctor Carole Harris. Medical Oncologist, St George and Sutherland Hospitals; Clinical Lecturer University of New South Wales.
Associate Professor Craig Gedye. Conjoint Associate Professor, School of Medicine and Public Health, The University of Newcastle; Senior Staff Specialist, Calvary Mater Newcastle; Director, HMRI Clinical Trials; Clinical Research Director, NSW Statewide Biobank; Chair, Renal Cancer Subcommittee, ANZUP Cancer Trials Group.
This webinar was developed independently by the limbic. Thank you to Bristol Myers Squibb Pty Ltd for providing the financial support that made it possible.
